Intended for healthcare professionals


Hormone therapy increases breast cancer risk in transgender women, study finds

BMJ 2019; 365 doi: (Published 15 May 2019) Cite this as: BMJ 2019;365:l2221
  1. Elisabeth Mahase
  1. The BMJ

Transgender women who take hormone therapy have a higher risk of breast cancer than the general male population but a lower risk than the general female population, a study has reported.

The paper, published in The BMJ,1 also found that the time between exposure to hormone treatment and breast cancer diagnosis was relatively short in transgender women (median 18 years), suggesting a “rapid” development of breast …

View Full Text

Log in

Log in through your institution


* For online subscription